Skip to main content
Clinical Trials/EUCTR2017-000787-15-ES
EUCTR2017-000787-15-ES
Active, not recruiting
Phase 1

Phase IV clinical trial for evaluating the utility in clinical practice of a predictive system of incorrect colonic preparation in patients derived for ambulatory colonoscopy

Antonio Zebenzui Gimeno García0 sites300 target enrollmentJune 22, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Antonio Zebenzui Gimeno García
Enrollment
300
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 22, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Antonio Zebenzui Gimeno García

Eligibility Criteria

Inclusion Criteria

  • Patients 18\-85 years old
  • Ambulatory candidates to colonoscopy
  • Informe consent signed
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 200
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 100

Exclusion Criteria

  • colonic or small bowel resection, gastroparesia, pseudo obstruction, megacolon, bowel perforation, uncontrolled hypertension, CCI, CKF, pregnants, knowed hypersensibility to components, dementia with dysphagia, previous inclusión in the study, Boston scale under 6points in previous test

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
A clinical trial to study the safety and efficacy of Pulmosil (Sildenafil Injection) for the treatment of hypertension.Health Condition 1: null- Pulmonary Arterial Hypertension.
CTRI/2016/11/007424Sun Pharmaceutical Industries Limited
Active, not recruiting
Phase 1
Clinical phase IV study assessing the efficacy and safety of the medicinal product Groprinosin in treatment of recurrent airway inflammation in children with impaired cellular immunity and diagnosed or undiagnosed allergic diseaseRecurrent airway inflammation in children with impaired cellular immunity.Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2013-003303-18-PLGedeon Richter Polska Sp. z o. o.
Recruiting
Not Applicable
Trial to evaluate efficacy and safety of modified new drug of Pranlukast(Prakanon), compared with Pranlukast (Onon®)Diseases of th respiratory system
KCT0000457Ewha Womans University Medical Center40
Active, not recruiting
Phase 1
Phase 4 clinical trial to evaluate the effect on immune recovery of antiretroviral treatment of three drugs versus two in in HIV-infected patients but not dectactable in blood.Adult patients with HIV infection on stable therapy (= 6 months) with triple therapy and undetectable viremia for = 1 year.MedDRA version: 19.1Level: LLTClassification code 10049838Term: HIV viral load undetectableSystem Organ Class: 100000004848MedDRA version: 19.1Level: PTClassification code 10077716Term: HIV viraemiaSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Not possible to specify
EUCTR2016-005226-11-ESFundación Pública Andaluza para la Gestión en Salud de Sevilla (FISEVI)180
Completed
Phase 4
A Phase IV, monocentric, clinical trial to evaluate and compare the number of nicks and cuts among three different shaving systems on healthy Indian men.
CTRI/2011/07/001890Procter and Gamble50